Internal medicine

Radiology

Pathology

Disease

Fibrosis

Liver fibrosis

Biology

Gastroenterology

Magnetic resonance imaging

Ultrasound

Stage (stratigraphy)

Paleontology

Elastography

Fatty liver

Magnetic resonance elastography

Medicine

Journal of Hepatology

Patients with non-alcoholic fatty liver disease (NAFLD) and significant fibrosis (fibrosis stage ≥2) are candidates for pharmacological trials. The aim of this study was to perform a head-to-head comparison of the diagnostic test characteristics of three non-invasive stiffness-based models including MEFIB (magnetic resonance elastography [MRE] plus FIB-4), MAST (magnetic resonance imaging [MRI]-aspartate aminotransferase [AST]), and FAST (FibroScan-AST) for detecting significant fibrosis.

Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD